Back

Prognostic value of right ventricular systolic function in cardiac amyloidosis

24 May 2016 (10:06 - 10:12)
Organised by:
Congress Presentation Part of: Moderated Poster Session 6 - Comorbidities Cardiomyopathies HFA Premium Access HEART FAILURE 2016

About the speaker

Photo
Doctor Diane Bodez

University Hospital Henri Mondor, Creteil (France)

9 More presentations in this session

Presentation thumbnail
3-month survival of the improvement of functional capacity after in-hospital short courses of leg neuromuscular electric stimulation in patients with decompensated chronic heart failure
Professor M. Poltavskaya (Moscow, RU)
Abstract Slides
Presentation thumbnail
Estimated glomerular filtration rate formulas and acute heart failure: does it worth to complicate?
Doctor M. Madeira (Coimbra, PT)
Abstract
Presentation thumbnail
Ergoreflex overactivity in mitochondrial disease: linking skeletal myopathy to exercise intolerance, dysautonomia, and cardiac damage
Doctor A. Aimo (Pisa, IT)
Abstract Slides
Presentation thumbnail
Efficacy and safety of didpeptidyl peptidase 4 inhibitors in patients with type 2 diabetes mellitus: a meta-analysis of 116 trials
Doctor G. Savarese (Stockholm, SE)
Abstract Slides
Presentation thumbnail
Cardiovascular prognosis in hypertrophic cardiomyopathy: insights from cardiopulmonary exercise testing.
Doctor M. Casenghi (Rome, IT)
Abstract Slides

Access the full session

Session thumbnail
Moderated Poster Session 6 - Comorbidities

The Event

Event poster

HEART FAILURE 2016

24 May 2016 10:06 CET
You may be interested in
thumbnail
Congress Presentation
Right ventricular systolic function predicts survival in patients with cardiac amyloidosis.
22 May 2023
thumbnail
Congress Session
Amyloidosis – what to look for?
17 May 2025
thumbnail
Congress Presentation
Left ventricular diastolic dysfunction in cardiac amyloidosis versus true heart failure with preserved ejection fraction
11 May 2024
thumbnail
Congress Presentation
Validation of a clinical score for transthyretin amyloid cardiomiopathy in a mediterranean cohort of patients at risk
21 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources